Arcutis Biotherapeutics (ARQT) Other Working Capital Changes (2020 - 2025)
Arcutis Biotherapeutics has reported Other Working Capital Changes over the past 6 years, most recently at $1.3 million for Q4 2025.
- Quarterly results put Other Working Capital Changes at $1.3 million for Q4 2025, down 15.38% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (up 111.71% YoY), and the annual figure for FY2025 was $2.0 million, up 111.71%.
- Other Working Capital Changes for Q4 2025 was $1.3 million at Arcutis Biotherapeutics, up from $1.1 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for ARQT hit a ceiling of $12.7 million in Q1 2021 and a floor of -$9.5 million in Q3 2021.
- Median Other Working Capital Changes over the past 5 years was -$160000.0 (2023), compared with a mean of $599263.2.
- Peak annual rise in Other Working Capital Changes hit 29548.84% in 2021, while the deepest fall reached 71350.0% in 2021.
- Arcutis Biotherapeutics' Other Working Capital Changes stood at -$23000.0 in 2021, then skyrocketed by 8213.04% to $1.9 million in 2022, then soared by 388.21% to $9.1 million in 2023, then tumbled by 83.59% to $1.5 million in 2024, then dropped by 15.38% to $1.3 million in 2025.
- The last three reported values for Other Working Capital Changes were $1.3 million (Q4 2025), $1.1 million (Q3 2025), and -$204000.0 (Q2 2025) per Business Quant data.